CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a phase IIIb, interventional, single arm, multicentre study assessing the safety profile of durvalumab in combination with carboplatin-paclit...
Phase 3
Valencia, Spain and 24 other locations
for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...
Phase 3
Valencia, Spain and 77 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Valencia, Valenciana, Comunitat, Spain and 230 other locations
study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...
Phase 3
Valencia, Spain and 94 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Valencia, Spain and 168 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
Valencia, Spain and 168 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Valencia, Valenciana, Comunitat, Spain and 73 other locations
This is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced or metastatic solid tumors. The study is e ...
Phase 2
Valencia, Spain and 53 other locations
This interventional study will evaluate the efficacy and safety of ART0380 as monotherapy in patients whose tumors have a biology to predict...
Phase 2
Valencia, Spain and 14 other locations
The goal of this clinical trial is to evaluate the safety of TOS-358 in adults with select solid tumors who meet study enrollment criteria. ...
Phase 1
Valencia, Spain and 19 other locations
Clinical trials
Research sites
Resources
Legal